Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, biopsy, and various therapies. Combining therapies with complementary ...
The AMPLITUDE trial showed Zejula's efficacy in extending progression-free survival in metastatic hormone-sensitive prostate cancer with HRR gene defects. Achieving a PSA level below 0.2 in prostate ...
Incidence of symptomatic hypoxia in a high-altitude cohort of patients with renal cell carcinoma (RCC) treated with belzutifan.
Experts from around the world will gather in San Francisco for the 2026 ASCO Genitourinary Cancers Symposium (ASCO GU 2026), which will be held February 26 to February 28. Here, Drs Benjamin Croll and ...
11 scientific abstracts, including 4 oral presentations and a concurrent publication in Nature Medicine, underscore how Signatera MRD can improve quality of life for patients with genitourinary ...
Minimally invasive surgery in genitourinary oncology has undergone significant transformation in recent years due to the integration of advanced ...
NEW YORK--(BUSINESS WIRE)-- Flatiron Health today announced its presence at the American Society of Genitourinary Cancers Symposium happening from February 26-28, 2026, in San Francisco, California.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results